Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind dose-controlled study of dexmedetomidine for sedation in mechanically ventilated pediatric ICU patients
2017-000320-10Phase 3
- Sponsor
- Hospira, Inc.
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Hospira, Inc.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2017-000320-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000320-10.